| Matthew Koval, | |
|
6534 Anthony Dr Ste C, Victor, NY 14564-1403 | |
| (585) 869-5140 | |
| Not Available |
| Full Name | Matthew Koval |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 6534 Anthony Dr Ste C, Victor, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285147009 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 042389 (New York) | Primary |
| Provider Name | Optimum Health And Wellness Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649577578 PECOS PAC ID: 3870775604 Enrollment ID: O20110315000559 |
News Archive
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
A new study from Helsinki University, published in the journal Scientific Reportson November 27, 2019, shows the application of an artificial intelligence (AI) algorithm to predict the risk of acute death following severe traumatic brain injury (TBI).
The Wall Street Journal: The Obama administration said Thursday that Health and Human Services Secretary Kathleen Sebelius will "exercise her discretion" in enforcing the medical loss ratio requirement of the health law. The comment comes after a report in The Journal Thursday that "McDonald's warned federal regulators it could drop its health-insurance plan for nearly 30,000 restaurant workers unless regulators waive a new requirement of the health overhaul.
Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.
At the annual Society for Laboratory Automation and Screening (SLAS) meeting Hamilton Robotics has announced a partnership with Coastal Genomics to launch the new Microlab® NIMBUS® Select workstation with Ranger Technology. The new automated workstation provides a faster and more economical automated solution to agarose gel selection of DNA fragments, generating high-quality material for downstream use in next-generation sequencing (NGS), cloning and gene synthesis applications.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Koval, 6534 Anthony Dr Ste C, Victor, NY 14564-1403 Ph: () - | Matthew Koval, 6534 Anthony Dr Ste C, Victor, NY 14564-1403 Ph: (585) 869-5140 |
News Archive
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
A new study from Helsinki University, published in the journal Scientific Reportson November 27, 2019, shows the application of an artificial intelligence (AI) algorithm to predict the risk of acute death following severe traumatic brain injury (TBI).
The Wall Street Journal: The Obama administration said Thursday that Health and Human Services Secretary Kathleen Sebelius will "exercise her discretion" in enforcing the medical loss ratio requirement of the health law. The comment comes after a report in The Journal Thursday that "McDonald's warned federal regulators it could drop its health-insurance plan for nearly 30,000 restaurant workers unless regulators waive a new requirement of the health overhaul.
Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.
At the annual Society for Laboratory Automation and Screening (SLAS) meeting Hamilton Robotics has announced a partnership with Coastal Genomics to launch the new Microlab® NIMBUS® Select workstation with Ranger Technology. The new automated workstation provides a faster and more economical automated solution to agarose gel selection of DNA fragments, generating high-quality material for downstream use in next-generation sequencing (NGS), cloning and gene synthesis applications.
› Verified 7 days ago
Allysyn Marie O'connell, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 590 Fishers Station Dr Ste 130, Victor, NY 14564 Phone: 585-924-7207 | |
Taylor Bowen, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6534 Anthony Dr Ste C, Victor, NY 14564 Phone: 585-869-5140 | |
Owen Memelo, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 7387 Pittsford Victor Rd Ste 950, Victor, NY 14564 Phone: 585-924-3250 Fax: 585-924-5127 | |
Meg Demario-macbain, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 590 Fishers Station Dr, Suite 130, Victor, NY 14564 Phone: 585-924-7207 | |
Alexander Thomas Kopicki, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7387 Pittsford Victor Rd Ste 950, Victor, NY 14564 Phone: 585-924-3250 | |
Diana Hutton, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 590 Fishers Station Dr, Suite 130, Victor, NY 14564 Phone: 585-924-7207 | |
Victor Physical Therapy, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 274 W Main St, Victor, NY 14564 Phone: 585-924-3250 Fax: 585-924-5127 |